🔎 Trials Near Me

Hjem › Venstreventrikkeldysfunksjon › New York

Kliniske studier for Venstreventrikkeldysfunksjon i New York

4 studier for Venstreventrikkeldysfunksjon søker deltakere på steder i New York.

Byer i New York

Offisiell studietekst (engelsk)

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

  • Columbia University Medical Center-Pediatric Cardiology ( Site 0016), New York
  • The Children's Hospital at Montefiore ( Site 0030), The Bronx
RekruttererFase 2/3
29 Days – 17 Years · Alle kjønn · Oppdatert 28. aug. 2026 · NCT05714085

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

  • Icahn School of Medicine at Mount Sinai - Pediatric Cardiology, New York
  • Columbia University Irving Medical Center - Pediatric Cardiology, New York
  • The Children's Hospital at Montefiore - Cardiology, The Bronx
RekruttererFase 3
Opp til 18 år · Alle kjønn · Oppdatert 29. jun. 2026 · NCT07192952

A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

  • Icahn School of Medicine at Mount Sinai - Pediatric Cardiology, New York
  • Columbia University Irving Medical Center - Pediatric Cardiology, New York
  • The Children's Hospital at Montefiore - Cardiology, The Bronx
RekruttererFase 3
6 Months – 17 Years · Alle kjønn · Oppdatert 15. jun. 2026 · NCT07188805

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

  • Mount Sinai Hospital, New York
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 1. jun. 2026 · NCT06699056

Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.